The Osteocyte: Key Player in Regulating Bone Turnover

Overview

Journal RMD Open

Publisher BMJ Publishing Group

Specialty Rheumatology

Date 2015 Nov 12

PMID 26557372

Citations 53

Authors

Steven R Goldring

Affiliations

Soon will be listed here.

Abstract

Osteocytes are the most abundant cell type in bone and are distributed throughout the mineralised bone matrix forming an interconnected network that ideally positions them to sense and to respond to local biomechanical and systemic stimuli to regulate bone remodelling and adaptation. The adaptive process is dependent on the coordinated activity of osteoclasts and osteoblasts that form a so called bone multicellular unit that remodels cortical and trabecular bone through a process of osteoclast-mediated bone resorption, followed by a phase of bone formation mediated by osteoblasts. Osteocytes mediate their effects on bone remodelling via both cell-cell interactions with osteoclasts and osteoblasts, but also via signaling through the release of soluble mediators. The remodelling process provides a mechanism for adapting the skeleton to local biomechanical factors and systemic hormonal influences and for replacing bone that has undergone damage from repetitive mechanical loading.

Citing Articles

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.

Chen Y, Xiao H, Liu Z, Teng F, Yang A, Geng B Biomolecules. 2024; 14(8).

PMID: 39199358 PMC: 11352324. DOI: 10.3390/biom14080970.

Daratumumab Treatment for "Truly Frail" Elderly Myeloma Patients.

Horigome Y, Suzuki K, Suzuki T Life (Basel). 2024; 14(3).

PMID: 38541713 PMC: 10971975. DOI: 10.3390/life14030389.

YAP/TAZ as Molecular Targets in Skeletal Muscle Atrophy and Osteoporosis.

Kwon Y Aging Dis. 2024; .

PMID: 38502585 PMC: 11745433. DOI: 10.14336/AD.2024.0306.

Pip5k1c expression in osteocytes regulates bone remodeling in mice.

Lin S, Tao C, Yan Q, Gao H, Qin L, Zhong Y J Orthop Translat. 2024; 45:36-47.

PMID: 38495744 PMC: 10943313. DOI: 10.1016/j.jot.2023.10.008.

Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies.

Di Paola A, Marrapodi M, Di Martino M, Giliberti G, Di Feo G, Rana D Int J Mol Sci. 2024; 25(5).

PMID: 38474150 PMC: 10932404. DOI: 10.3390/ijms25052902.

References

Chan B, Fuller E, Russell A, Smith S, Smith M, Jackson M . Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage. 2011; 19(7):874-85. DOI: 10.1016/j.joca.2011.04.014. View

Bellido T, Saini V, Divieti Pajevic P . Effects of PTH on osteocyte function. Bone. 2012; 54(2):250-7. PMC: 3552098. DOI: 10.1016/j.bone.2012.09.016. View

Rhee Y, Allen M, Condon K, Lezcano V, Ronda A, Galli C . PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. J Bone Miner Res. 2010; 26(5):1035-46. PMC: 3179307. DOI: 10.1002/jbmr.304. View

Ben-awadh A, Delgado-Calle J, Tu X, Kuhlenschmidt K, Allen M, Plotkin L . Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014; 155(8):2797-809. PMC: 4098003. DOI: 10.1210/en.2014-1046. View

Morse A, McDonald M, Kelly N, Melville K, Schindeler A, Kramer I . Mechanical load increases in bone formation via a sclerostin-independent pathway. J Bone Miner Res. 2014; 29(11):2456-67. PMC: 4501925. DOI: 10.1002/jbmr.2278. View

Purdue P, Crotti T, Shen Z, Swantek J, Li J, Hill J . Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate. Sci Rep. 2014; 4:7595. PMC: 4274512. DOI: 10.1038/srep07595. View

Robling A, Niziolek P, Baldridge L, Condon K, Allen M, Alam I . Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2007; 283(9):5866-75. DOI: 10.1074/jbc.M705092200. View

Quarles L . Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol. 2012; 8(5):276-86. PMC: 4489419. DOI: 10.1038/nrendo.2011.218. View

Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng J . Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17(10):1231-4. DOI: 10.1038/nm.2452. View

10.

Caballero-Alias A, Loveridge N, Pitsillides A, Parker M, Kaptoge S, Lyon A . Osteocytic expression of constitutive NO synthase isoforms in the femoral neck cortex: a case-control study of intracapsular hip fracture. J Bone Miner Res. 2005; 20(2):268-73. DOI: 10.1359/JBMR.041103. View

11.

Sheng M, Lau K, Baylink D . Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone. J Bone Metab. 2014; 21(1):41-54. PMC: 3970294. DOI: 10.11005/jbm.2014.21.1.41. View

12.

Eriksen E . Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord. 2010; 11(4):219-27. PMC: 3028072. DOI: 10.1007/s11154-010-9153-1. View

13.

Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013; 19(2):179-92. DOI: 10.1038/nm.3074. View

14.

Cardoso L, Herman B, Verborgt O, Laudier D, Majeska R, Schaffler M . Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res. 2008; 24(4):597-605. PMC: 2659511. DOI: 10.1359/jbmr.081210. View

15.

Heino T, Hentunen T, Vaananen H . Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem. 2002; 85(1):185-97. DOI: 10.1002/jcb.10109. View

16.

Keller H, Kneissel M . SOST is a target gene for PTH in bone. Bone. 2005; 37(2):148-58. DOI: 10.1016/j.bone.2005.03.018. View

17.

Kennedy O, Herman B, Laudier D, Majeska R, Sun H, Schaffler M . Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012; 50(5):1115-22. PMC: 3366436. DOI: 10.1016/j.bone.2012.01.025. View

18.

Schaffler M, Cheung W, Majeska R, Kennedy O . Osteocytes: master orchestrators of bone. Calcif Tissue Int. 2013; 94(1):5-24. PMC: 3947191. DOI: 10.1007/s00223-013-9790-y. View

19.

Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K . Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007; 5(6):464-75. DOI: 10.1016/j.cmet.2007.05.001. View

20.

Yin J, Hao Z, Ma Y, Liao S, Li X, Fu J . Concomitant activation of the PI3K/Akt and ERK1/2 signalling is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells. Cell Biol Int. 2013; 38(5):591-8. DOI: 10.1002/cbin.10235. View